Uniwersytecki Szpital Dzieciecy w Krakowie
About Uniwersytecki Szpital Dzieciecy w Krakowie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Takeda
8
Janssen Research & Development, LLC
4
Actelion
2
Amgen
2
Société des Produits Nestlé (SPN)
2
Arbor Pharmaceuticals, Inc.
1
Eli Lilly and Company
1
EusaPharma (UK) Limited
1
Ferring Pharmaceuticals
1
Ipsen
1
MediWound Ltd
1
Clinical Trials at Uniwersytecki Szpital Dzieciecy w Krakowie
During the past decade, Uniwersytecki Szpital Dzieciecy w Krakowie conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 5 clinical trials were completed, i.e. on
average, 20.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Zomacton in Children With Growth Hormone Deficiency
2010-01-01
2012-07-01
Completed
165
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
2014-02-05
2021-03-10
Completed
35
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
2014-12-19
2020-09-27
Completed
215
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
2015-05-01
2022-12-01
Active, not recruiting
145
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
2015-02-16
2026-02-22
Recruiting
118
Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases
2015-04-01
2023-04-01
Active, not recruiting
106
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
2025-06-15
2025-12-23
Withdrawn
0
A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children
2023-03-31
2027-11-17
Not yet recruiting
76
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Uniwersytecki Szpital Dzieciecy w Krakowie" #1 sponsor was "Takeda" with 8 trials, followed by "Janssen Research & Development, LLC" with 4 trials
sponsored, "Actelion" with 2 trials sponsored, "Amgen" with 2 trials sponsored and "Société des Produits Nestlé (SPN)"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersytecki Szpital Dzieciecy w Krakowie"
#1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator, "Celerion" with 1 trials as a collaborator, "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Uniwersytecki Szpital Dzieciecy w Krakowie
According to Clinical.Site data, the most researched conditions in "Uniwersytecki Szpital Dzieciecy w Krakowie" are
"Colitis, Ulcerative" (4 trials), "Crohn's Disease" (3 trials), "Crohn Disease" (2 trials), "Hypertension, Pulmonary" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Uniwersytecki Szpital Dzieciecy w Krakowie" in a lesser frequency.
Clinical Trials Intervention Types at Uniwersytecki Szpital Dzieciecy w Krakowie
Most popular intervention types in "Uniwersytecki Szpital Dzieciecy w Krakowie" are "Drug" (22 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Vedolizumab" (3 trials), "Dexlansoprazole" (2 trials), "Ustekinumab" (2 trials) and "6-Mercaptopurine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uniwersytecki Szpital Dzieciecy w Krakowie
The vast majority of trials in "Uniwersytecki Szpital Dzieciecy w Krakowie" are
27 trials for "All" genders.
Clinical Trials Status at Uniwersytecki Szpital Dzieciecy w Krakowie
Currently, there are NaN active trials in "Uniwersytecki Szpital Dzieciecy w Krakowie".
1 are not yet recruiting,
11 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Uniwersytecki Szpital Dzieciecy w Krakowie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uniwersytecki Szpital Dzieciecy w Krakowie, 3 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Uniwersytecki Szpital Dzieciecy w Krakowie
Uniwersytecki Szpital Dzieciecy w Krakowie has several departments that took part in Clinical trials: "University Children's Hospital" - 5 trials
Departments List
Name
City
Trials